Clinical trials
Active, not recruiting Aortic Valve Stenosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Edwards Lifesciences | 6 |
| Abbott Medical Devices | 4 |
| Anteris Technologies Ltd. | 3 |
| Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | 3 |
| Medtronic Cardiovascular | 3 |
| Boston Scientific Corporation | 2 |
| Cardiovascular Research Foundation, New York | 2 |
| Medical University of Vienna | 2 |
| Radboud University Medical Center | 2 |
| Rigshospitalet, Denmark | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Valve Stenosis | 69 |
| Cardiovascular Diseases | 10 |
| Heart Valve Diseases | 10 |
| Aortic Valve Disease | 8 |
| Heart Diseases | 7 |
| Aortic Valve Insufficiency | 5 |
| Coronary Artery Disease | 5 |
| Mitral Valve Insufficiency | 3 |
| Arrhythmias, Cardiac | 2 |
| Atrial Fibrillation | 2 |
Trials
Showing 26 to 50 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.